Regulus Therapeutics
RGLS
#7143
Rank
A$0.79 B
Marketcap
A$11.54
Share price
0.00%
Change (1 day)
391.91%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: A$0.79 Billion

On August 27, 2025 Regulus Therapeutics had a market cap of A$0.79 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025A$0.84 B420.11%
2024A$0.16 B326.84%
2023A$37.99 M12.07%
2022A$33.9 M-46.54%
2021A$63.42 M-43.11%
2020A$0.11 B317.29%
2019A$26.71 M129.37%
2018A$11.64 M-91.59%
2017A$0.13 B-16.17%
2016A$0.16 B-73.8%
2015A$0.63 B-34.28%
2014A$0.95 B177.08%
2013A$0.34 B59.38%
2012A$0.21 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
A$146.94 B 18,293.39%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$42.05 B 5,163.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$161.33 B 20,094.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$393.31 B 49,132.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$148.85 B 18,532.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
A$0.10 B-87.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
A$4.21 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$53.66 B 6,617.34%๐Ÿ‡บ๐Ÿ‡ธ USA